KDB Tifa Finance Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? KDB Tifa Finance Tbk. trades at Rp304 (market cap 866.74B, 1.53M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 13.5× KDB Tifa Finance Tbk.'s market cap, and KDB Tifa Finance Tbk. is more actively traded (1.53M versus 429.7K). Which is the better fit depends on your goals.
| TIFA | TSPC | |
|---|---|---|
Market Cap | 866.74B | 11.68T |
Volume | 1.53M | 429.7K |
Lot | 15.29K | 4.3K |
Turnover | 450.9M | 1.11B |
Average Price | 294.96 | 2,591.65 |
Value | 450.9M | 1.11B |
Indicative Equilibrium Price | 304 | 2,580 |
Indicative Equilibrium Volume | 4 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Tifa Finance Tbk (the company) was established under its original name of PT Tifa Mutual Finance Corporation base on notarial deed No.42 of Esther Daniar, S.H, dated on 14 Jun, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No. 1 of Fathiah Helmi, S.H., dated Aug 2, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on TIFA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →